Acetylsalicylic acid (Aspirin, BAYE4465) + Acetylsalicylic acid (Aspirin, BAYE4465) + Ibuprofen + Ibuprofen + Placebo
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Headache
Conditions
Headache, Tension-Type Headache, Tension-Type Headache (Episodic)
Trial Timeline
Jan 1, 2004 → Aug 1, 2004
NCT ID
NCT01464983About Acetylsalicylic acid (Aspirin, BAYE4465) + Acetylsalicylic acid (Aspirin, BAYE4465) + Ibuprofen + Ibuprofen + Placebo
Acetylsalicylic acid (Aspirin, BAYE4465) + Acetylsalicylic acid (Aspirin, BAYE4465) + Ibuprofen + Ibuprofen + Placebo is a approved stage product being developed by Bayer for Headache. The current trial status is completed. This product is registered under clinical trial identifier NCT01464983. Target conditions include Headache, Tension-Type Headache, Tension-Type Headache (Episodic).
What happened to similar drugs?
8 of 20 similar drugs in Headache were approved
Approved (8) Terminated (1) Active (11)
Hype Score Breakdown
Clinical
20
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01464983 | Approved | Completed |
Competing Products
20 competing products in Headache